NCT05573425View on ClinicalTrials.gov

Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

August 22, 2020

Primary Completion Date

February 21, 2021

Study Completion Date

February 21, 2021

Conditions
Acne Scar
Interventions
DRUG

Tazarotene gel 0.1%

Tazarotene gel 0.1% applied daily on Acne Scars.

DEVICE

Microneedling

Microneedling via dermaroller device performed on Acne Scars monthly.

Trial Locations (1)

75510

Jinnah Post graduate medical center, Karachi

All Listed Sponsors
lead

Jinnah Postgraduate Medical Centre

OTHER_GOV

NCT05573425 - Comparing the Efficacy of Topical Tazarotene Gel 0.1% v/s Microneedling in Atrophic Post Acne Scars | Biotech Hunter | Biotech Hunter